Mikhail Blagosklonny and the Amazing Healing Properties of Rapamycin

Modern medicine keeps on advancing each day. One medicine that has been very effective in carrying out a number of procedures has been Rapamycin or Sirolimus. Among the many uses of this drug include the treatment of uncommon lung diseases, acts as a coat for coronary stents, and lastly helps in preventing organ transplant rejection.Rapamycin, however, is not a new medicine in the world. This drug was discovered in 1972; however, it was majorly used as an anti-fungal agent. With the advancement in research operations, this drug was discovered to have a lot of benefits including being a great antiproliferative and immunosuppressive. It is as a result of these features that physicians and researchers such as Mikhail Blagosklonny have endorsed it for the treatment of cancer. The following are some of the benefits of Rapamycin according to Mikhail Blagosklonny.

Helps in Treating Patients With Hemolytic-Uremic Syndrome

Hemolytic-uremic syndrome is a condition caused due to the combination of kidney failure, low platelet count, and anemia. This condition is fatal as it may results in renal failure hence leading a patient to be dependent on dialysis all of his or her lifetime. The only preventative cure for this condition is always through kidney transplants. Unlike with calcineurin inhibitors, Rapamycin has a high probability of helping you succeed in the transplant operations as it lowers the toxicity levels in your kidneys.

Treatment of Cancer

Mikhail Blagosklonny is a lead researcher when it comes to cancer. According to his research, Rapamycin’s antiproliferative properties are what helps this drug to be effective in the treatment of cancer. This drug works in two ways; first, it helps boosts our body’s immunity response. Secondly, its effects help to suppress the growth of the cancer tumor thus helping reduce the risks of cancer in patients and more so those undergoing organ transplants.

About Mikhail Blagosklonny and his Plan for Oncology

Mikhail Blagosklonny is one of the most respected scientists in the field of oncology. With cancer being one of the world’s biggest medical menaces, Mikhail Blagosklonny, through his researches, is committed to helping patients and their family ease on the cancer burden. Currently, Dr. Mikhail Blagosklonny is a professor, editor, and researcher at New York’s Rosewell Park Cancer Institute in Buffalo where he also gets to play his editorial duties at OncorTarget an online oncology publication.Dr. Mikhail Blagosklonny has to his name a number of published research works. His specialty is in the area of cancer and the effects of aging. Mikhail Blagosklonny is seeking to establish how these two areas can be merged to help come up with an effective cure for cancer. So far the progress is good if the OncorTarget publication is anything to go by. This publication has been able to attract many online readers thus creating a rich source of affordable information to both researchers and the general public leading to improved quality of life.Going into the future, Mikhail Blagosklonny has more plans not only for himself but also for his publication. He seeks to improve the quality of life and make life more bearable for cancer patients and their families by creating a cure and making the cancer information available.

Rapamycin’s Role in Aging and IntegraGen’s New EPOC Study as Published on Oncotarget

A new Oncotarget article suggests that gut homeostasis plays a crucial role in the bodies of aging individuals. It also suggests that a mTOR specific inhibitor known as rapamycin has enhanced longevity in diverse evolutionary species. The inhibitor reduces the rate at which proliferation takes place in the intestinal cells. Rapamycin also slows down the expansion of microbes in aging guts. It keeps the stem cells active by inhibiting mTOR. These results are used in explaining how lifespan and healthspan can be extended in Drosophila.

IntegraGen’s New EPOC Study

In a move to avail results of a new clinical trial online, IntegraGen released new publication on the Oncotarget online journal. The company’s top scientists got the results after they analyzed miR-31-3p expression in patients’ tumor samples. The publication also explains the relationship between the efficacy of anti-EGFR treatment and miR-31-3p expression. It also explains the findings of the clinical study known as the NEW EPOC Study.Prof. John Bridgewater, a medical oncologist, partnered with other researchers in authoring the report of this innovative study. Prof. Bridgewater, who was also an investigator in the study, said that his team is honored to continue availing clinical research from the New EPOC Study. He mentioned that the data emancipates clinicians on therapies for metastatic colorectal cancer. The data helps in advancing cancer research and enhancing the healthspan and lifespan of patients with metastatic colorectal cancer.IntraGen’s molecular diagnostics director, Yann Gaston-Mathé, pointed out that the study is a manifestation of his company’s commitment to developing precision medicine therapies. Besides posting an article on Oncotarget, IntraGen signed a licensing deal together with CEBRA Laboratories. The deal allows the two companies to collaborate in developing a test that can be used in measuring miR-31-3p expression.

About Oncotarget

With an impact factor of 5.168, Oncotarget has gained recognition in the field of medicine as an open access and weekly peer-reviewed journal. Its publications cover scientific and clinical research on oncology. Since its release in 2010, Andrei Gudkov and Mikhail Blagosklonny have been serving as the senior editors. Oncotarget’s publications are usually indexed and abstracted in Scopus, Index Medicus/ PubMed, Science Citation Index Expanded and BIOSIS Previews.

InnovaCare: The Incredible Company Aiming To Alter The Healthcare Field

InnovaCare is a company that aims to change the way the healthcare sector in North America treats its patients and offers its services. The company is one of a kind, and provides numerous medical facilities to patients, without charging them exorbitant fees for the same. Since its inception, the company has offered their services to millions of patients around the country. The company has always tried to stay in touch with the people, to see what they need regarding medical services. The company listens to their patients and aims to always provide top quality services to them. They know that every one of their patients that come to them is different and requires different things from their list of medical services. For this purpose, the company has a diverse range of healthcare plans, so that patients have all their bases covered.

InnovaCare works on a system of membership, where by those who wish to seek their medical services can log onto their website and register with them. Since disease and illnesses can strike at any time, these patients can be ready if they need immediate medical attention. Thereon, they can go to any of the InnovaCare outlets and seek treatment immediately without any hassles. One of the things that make InnovaCare stand out from the crowd is their notion of offering affordable health care. Numerous people in the country do not seek proper health care merely because they could not afford it. InnovaCare is trying to change that by making their services accessible and affordable because having an illness treated shouldn’t burn a hole in one’s pocket.

One of the reasons why InnovaCare has become so successful is because of the incredible leaders in InnovaCare. The person currently leading InnovaCare is Dr. Rick Shinto, who is a practicing doctor who has worked in the medical sector and knew it inside out. He has an incredible amount of experience in the field, which is why he has proven to be such a beneficial leader to the company. Dr. Shinto has also been behind the current medical plans that the company has implemented.The other person who has played a significant role in the success of the company is Penelope Kokkinides. Having worked with numerous medical institutions in the past, Penelope Kokkinides is brilliant at handling the administrative side of things. She currently works as the Chief Administrative Officer of the company and assists Dr. Shinto is most of his affairs.

Excellent Prognosis for Those with Multiple Scleroris

A new research study advocates the hope of long-term remission of multiple sclerosis.

Five years after receiving the treatment, known as high-dose immunosuppressive therapy and hematopoietic cell transplant (HDIT/HCT) and transplantation of an individual’s own stem cells, 69 percent of participants continued to exist with no advancement of impairment, deterioration of MS symptoms or new brain lesions.

The National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health, subsidized the trial known as HALT-MS.

According to NIAID Director Anthony Fauci, M.D. the results of the trial indicate the one-time healing with HDIT/HCT may be to a large extent more successful than long-term treatment with existing medication.

For example, five years after HDIT/HCT, most trial participants continued to be in remission and their multiple sclerosis had become stable. Some even demonstrated signs of improvements, such as improvements in mobility or other physical abilities.

Motor and speech difficulties, weakness, fatigue and chronic pain are among the symptoms the disease may demonstrate. Taking part in the study were volunteers aged 26 to 52 with relapsing-remitting MS.

The researchers published the initial three-year results in December 2014 and the five-year results were published online in the medical journal of the American Academy of Neurology February 1.

A Voorhees, New Jersey-based practicing neurologist and specialist in psychiatry Dr. Shiva Gopal Vasishta is a member of the group practice Eastern Neurodiagnostic Associates.

Neurologists are doctors who diagnose, identify and care for sicknesses of the nervous system including the brain, nerves and spinal cord.

Dr. Shiva Gopal Vasishta received his medical degree from Government Medical College Nagpur and completed his residency at Boston City Hospital.

Affiliated with Kennedy Health System Cherry Hill Campus, Dr. Shiva Gopal Vasishta has practiced for forty years. Dr. Shiva Gopal Vasishta is board certified in neurology.

Leadership Change Brings Expertise to InnovaCare Health Government Programs

InnovaCare Health made an outstanding change in leadership with appointing Penelope Kokkinides as a Executive to their team in June 2015. Penelope Kokkinides joined the Fort Lee, New Jersey based company as their new Chief Administrative Officer. She has a master’s degree in social work from New York University, and a master’s degree in public health from Columbia University.

Since joining the organization she has been very involved in positioning the company’s Medicaid and Medicare programs and making significant improvements. Ms. Kokkinides has an extensive and distinguished resume for tackling such programs and she comes with a great amount of experience.

Prior to InnovaCare Health, Ms. Kokkinides already had an impressive 20 year history with companies such as Americhoice and Centerlight HealthCare. In both those companies Ms. Kokkinides held leadership roles within government programs and made significant changes for their success. In both companies she held the position of Vice President. She is considered a leading expert in her field and the reason chosen for creating the infrastructure which aligns with InnovaCare Health’s business objectives for their future. View her infographic resume at vizualize.me.

Ms. Penelope Kokkinides recently released a statement saying in part, “InnovaCare Health will constantly be committed to developing outstanding and cost-effective models, fully integrated with today’s most advanced technologies to transform healthcare.” Read more about her interview in Ideamensch

Healthcare reform has been a major topic in the nation within recent years and the implementation of modifications will be vital to InnovaCare Health. The Centers for Medicaid and Medicare (CMS) have released their proposed changes for 2018 which is intended to provide a more stable structure for program benefit reimbursements. This change comes at a time when InnovaCare Health has already led the charge in tackling waste and abuse of benefit reimbursements.

In October 2016, InnovaCare Health announced that one of its subsidiary Medicaid and Medicare programs was selected in the California Association of Physician Groups (CAPG). The organization conducts annual case studies of excellence which CAPG is the leading association in the country. InnovaCare Health will be representing physician organizations practicing capitated and coordinated care, which is a high priority for preventing government waste and abuse.

President and CEO Rick Shinto stated: “With the ongoing changes the healthcare industry continues to place on independent physicians, we needed to build physician support for our initiatives, engage patients in a more effective manner, and figure out how to collect data in a more timely and cost-effective way.”

InnovaCare Health continues to lead the industry with its choice in great leadership and in its commitment to providing quality healthcare to more than 200,000 members, served by almost 8,000 providers.

Things You Should Understand About Medicare Advantage

Medicare Advantage is a form of insurance that allows beneficiaries to receive cover after receiving medical attention. This is like a subscription service that allows members to enjoy certain services to a defined extent. Medicare Advantage is made up of two parts, Part A and Part B, which offer different benefits to members.

Part A Medicare Advantage allows beneficiaries to access in-patient, skilled nursing and hospice services with the exception of surgeons and physicians. On the other hand, part B Medicare Advantage provides for services like surgeries, physical treatment and other vital medical services like X-rays and ER.

How the plans work
Medicare Advantage plans are managed by private insurance firms and are as a result of government partnership with the selected insurance firms. Medicare submits monthly payment to the insurance firms, which in turn offer the benefits to members of the program. Medicare Advantage plans are available in different forms and one is advised to first review the benefits each offers.

Read more: InnovaCare Health | CrunchBase

It is also vital to understand the management of the process may make it possible to find some areas do not have certain plans, so it is advisable to confirm whether the plans you are after are available in your region. Rates and terms may also vary depending on the provider and region one comes from. The reason it is advisable to pay attention to the terms issued by the insurance company is because some offer zero interest and in some cases the out-of-pocket costs may exceed what other firms in the same market offer.

About InnovaCare Health
InnovaCare, a Puerto Rico based Medicare and physician practices provider, is an established company that is looking to revolutionize medical insurance. The company has invested heavily in technological additions that have eliminated the challenges that hinder efficiency and kill quality. InnovaCare Health is working around the clock to ensure healthcare management is redefined and patients access the best plans to cater for their needs.

The management
Dr. Rick Shinto, the current CEO and President of InnovaCare Health, is a professional with a huge industry experience. Apart from his vast experience, Dr. Richard Shinto holds academic qualifications that confirm his ability to drive a leading company like InnovaCare Health. He holds a B.S. from California University and pursued his M.B.A in Redlands University. Also vital in the management team is the Chief Operating Officer of InnovaCare, Penelope Kokkinides, an experienced leader who has also worked with various major companies prior to joining InnovaCare. She holds a degree in Public Health from University of Columbia.

Visit: https://www.openminds.com/market-intelligence/bulletins/innovacare-health-announces-three-additions-leadership-team/

A Wide Variety Of Business And Services Are Offered By Healthcare Companies

Healthcare is big business in this country. Healthcare companies around the United States are growing and thriving. Many of this companies own several separate facilities that offer a wide variety of services from diagnostic to surgical. When looking on stockhouse.com for a healthcare provider using one of the larger more reputable companies is a good option. They will use the best physicians and technicians to service you and your family’s medical and surgical needs. One such healthcare provider with an excellent reputation is Nobilis Health. Nobilis Health is a network of major and minor surgical procedure and diagnostic providers and individual surgical clinics around the country. Nobilis Health is a thriving company that owns several surgical centers in the United States that offer a wide variety of procedures for their clients. They have merged Northstar Healthcare and Athas Healthcare. Some of the centers that they have; Northstar Surgery Center in Dallas, Tx, Northstar Healthcare Surgery Center in Houston, TX, Northstar Healthcare Surgery Center in Scottsdale, AZ, The Kirby Surgical Center, Northstar Urgent Care and Surgery Center, Northstar Imaging Center, First Surgical Hospital and First Street Surgical Center, Hermann Drive Surgical Hospital, and Plano Surgical Hospital. Nobilis Healthcare manages over one hundred surgical centers around the country. Some of the services that they specialize in are spine surgery, pain management, orthopedic surgery, podiatry, general surgery, gastrointestinal scopes, Otolaryngology. Nobilis Health employs the most skilled board certified physicians in the country. Nobilis Health is also in the forefront of technology used in surgical procedures.